Precision strike: new combo therapy aims to control spreading prostate cancer
NCT ID NCT03902951
Summary
This study is testing a two-part treatment for prostate cancer that has returned and spread to a few other areas of the body. Patients receive hormone-blocking drugs for six months, combined with highly targeted radiation to the specific tumors. The goal is to see if this combined approach is effective at controlling the cancer and delaying its progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IVB PROSTATE CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.